​

Funding Round

Series A - Aeovian Pharmaceuticals

Series A - Aeovian Pharmaceuticals

Investment Firm

Overview

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

Announced Date

Mar 28, 2024

Closed on Date

Mar 28, 2024

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Hevolution

Hevolution

No designation

Participant Investors

6

Investor Name
Participant InvestorvenBio Partners
Participant InvestorEvotec
Participant InvestorSofinnova Investments
Participant InvestorApollo Health Ventures
Participant Investorb2venture

Round Details and Background

Aeovian Pharmaceuticals raised $50000000 on 2024-03-28 in Series A

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 12, 2017
Seed Round - Aeovian Pharmaceuticals
1-undefined
Oct 03, 2019
Series A - Aeovian Pharmaceuticals
4-37.0M
Mar 28, 2024
Series A - Aeovian Pharmaceuticals
6-50.0M

Recent Activity

There is no recent news or activity for this profile.